CTLT | Catalent
106.68 -3.16 (-2.88%)
CTLT Price Profile
- MRQ = Most Recent Quarter.
- TTM = Trailing Twelve Months.
Catalent (CTLT) company profile
Catalent Inc. (NYSE: CTLT) is a medical company that provides delivery technologies and development and manufacturing solutions for drugs, protein, cell, gene therapy biologics and consumer health products. It operates through the segments of Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. Catalent also provides packaging services, labelling, storage, distribution, and inventory management for clinical drug trials.